Latest News

New drugs offer hope for migraine prevention

Two new studies may offer hope for people with migraines. Both studies involve drugs that are aimed at preventing migraine attacks from occurring, rather than stopping the attacks once they have started. These studies are the first to test monoclonal antibodies for the prevention of migraine, and both are directed against a relatively new target in migraine prevention, the calcitonin gene-related peptide, or CGRP. CGRP has been thought to be important in migraine, but never have drugs been developed to specifically target the protein.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Love and intimacy in later life: Active sex lives surprisingly common in the over 70s

  • Can synesthesia be taught? Colored letters, tasty sounds?

  • Beer compound could help fend off Alzheimer's and Parkinson's diseases

  • Novel radioguided brain surgery technique could help pinpoint cancerous tissue

  • Concentrating on word sounds helps reading instruction and intervention

  • Molecular alterations in head and neck cancers uncovered by study

  • Why upper motor neurons degenerate in ALS

  • Cell imaging gets colorful

  • New theoretical framework for future studies of resilience

  • Playing with puzzles, blocks may build children's spatial skills

  •